ArriVent BioPharma, Inc. (AVBP) vs Helus Pharma Inc. (HELP)
A side-by-side comparison of ArriVent BioPharma, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$14.16HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
HELP
Helus Pharma Inc.
$10.79HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — AVBP vs HELP
growth of $100 · dividends reinvested · last 1yAVBP +13.9% (+13.9%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
AVBP HELP
AVBP vs HELP: by the numbers
- •HELP is the larger company ($669M vs $660M market cap).
- •HELP is profitable (329.09% net margin) while AVBP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AVBP | HELP |
|---|---|---|
| P/B ratio | 1.80 | 2.77 |
Profitability
| Metric | AVBP | HELP |
|---|---|---|
| Gross margin | 0.00% | 100.27% |
| Operating margin | 0.00% | 317.06% |
| Net margin | 0.00% | 329.09% |
| ROE | -44.63% | -75.79% |
| ROIC | -47.96% | -73.27% |
Frequently asked
- Is AVBP or HELP more profitable?
- HELP runs the higher net margin — AVBP at 0.00% versus HELP at 329.09%.
Go deeper
Dig into the metrics
ArriVent BioPharma ROEHelus Pharma ROEArriVent BioPharma operating marginHelus Pharma operating marginArriVent BioPharma revenue growthHelus Pharma revenue growthArriVent BioPharma free cash flowHelus Pharma free cash flow
ArriVent BioPharma & Helus Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.